TY - JOUR
T1 - Tuberculosis and COVID-19 in the elderly
T2 - factors driving a higher burden of disease
AU - Allué-Guardia, Anna
AU - Torrelles, Jordi B.
AU - Sigal, Alex
N1 - Publisher Copyright:
Copyright © 2023 Allué-Guardia, Torrelles and Sigal.
PY - 2023
Y1 - 2023
N2 - Mycobacterium tuberculosis (M.tb) and SARS-CoV-2 are both infections that can lead to severe disease in the lower lung. However, these two infections are caused by very different pathogens (Mycobacterium vs. virus), they have different mechanisms of pathogenesis and immune response, and differ in how long the infection lasts. Despite the differences, SARS-CoV-2 and M.tb share a common feature, which is also frequently observed in other respiratory infections: the burden of disease in the elderly is greater. Here, we discuss possible reasons for the higher burden in older adults, including the effect of co-morbidities, deterioration of the lung environment, auto-immunity, and a reduced antibody response. While the answer is likely to be multifactorial, understanding the main drivers across different infections may allow us to design broader interventions that increase the health-span of older people.
AB - Mycobacterium tuberculosis (M.tb) and SARS-CoV-2 are both infections that can lead to severe disease in the lower lung. However, these two infections are caused by very different pathogens (Mycobacterium vs. virus), they have different mechanisms of pathogenesis and immune response, and differ in how long the infection lasts. Despite the differences, SARS-CoV-2 and M.tb share a common feature, which is also frequently observed in other respiratory infections: the burden of disease in the elderly is greater. Here, we discuss possible reasons for the higher burden in older adults, including the effect of co-morbidities, deterioration of the lung environment, auto-immunity, and a reduced antibody response. While the answer is likely to be multifactorial, understanding the main drivers across different infections may allow us to design broader interventions that increase the health-span of older people.
KW - COVID-19
KW - Mycobacterium tuberculosis
KW - SARS-CoV-2
KW - TB
KW - elderly
KW - immunity
KW - infectious diseases
UR - https://www.scopus.com/pages/publications/85174160250
U2 - 10.3389/fimmu.2023.1250198
DO - 10.3389/fimmu.2023.1250198
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 37841265
AN - SCOPUS:85174160250
SN - 1664-3224
VL - 14
JO - Frontiers in Immunology
JF - Frontiers in Immunology
M1 - 1250198
ER -